z-logo
Premium
Effect of pre‐operative methylprednisolone on orthostatic hypotension during early mobilization after total hip arthroplasty
Author(s) -
LindbergLarsen V.,
Petersen P. B.,
Jans Ø.,
Beck T.,
Kehlet H.
Publication year - 2018
Publication title -
acta anaesthesiologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.738
H-Index - 107
eISSN - 1399-6576
pISSN - 0001-5172
DOI - 10.1111/aas.13108
Subject(s) - medicine , methylprednisolone , anesthesia , orthostatic vital signs , placebo , blood pressure , heart rate , surgery , alternative medicine , pathology
Background Orthostatic hypotension ( OH ) and intolerance ( OI ) are common after total hip arthroplasty ( THA ) and may delay early mobilization. The pathology of OH and OI includes a dysregulated post‐operative vasopressor response, by a hitherto unknown mechanism. We hypothesized that OI could be related to the inflammatory stress response which is inhibited by steroid administration. Consequently, this study evaluated the effect of a pre‐operative high‐dose methylprednisolone on OH and OI early after THA . Methods Randomized, double‐blind, placebo‐controlled study in 59 patients undergoing elective unilateral THA with spinal anesthesia and a standardized multimodal analgesic regime. Patients were allocated (1 : 1) to pre‐operative intravenous ( IV ) methylprednisolone ( MP ) 125 mg or isotonic saline (C). OH , OI and cardiovascular responses to sitting and standing were evaluated using a standardized mobilization protocol pre‐operatively, 6, and 24 h after surgery. Systolic and diastolic arterial pressure and heart rate were measured non‐invasively (Nexfin ® ). The systemic inflammation was monitored by the C‐reactive protein ( CRP ) response. Results At 6 h post‐operatively, 11 (38%) versus 11 (37%) patients had OH in group MP and group C, respectively ( RR 1.02 (0.60 to 1.75; P = 1.00)), whereas OI was present in 9 (31%) versus 13 (43%) patients ( RR 0.76 (0.42 to 1.36; P = 0.42)), respectively. At 24 h post‐operatively, the prevalence of OH and OI did not differ between groups, though CRP levels were significantly reduced in group MP ( P < 0.001). Conclusion Pre‐operative administration of 125 mg methylprednisolone IV did not reduce OH or OI compared with placebo despite a reduced inflammatory response.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom